A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population.
J Adolesc Health
; 67(6): 763-768, 2020 12.
Article
in English
| MEDLINE | ID: covidwho-872192
ABSTRACT
PURPOSE:
The aim of the study was to determine the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in a university student population.METHODS:
This was a cross-sectional survey study based on the World Health Organization population-based seroepidemiological investigational protocol for SARS-CoV-2 conducted between April 29, 2020, and May 8, 2020, examining SARS-CoV-2 antibody prevalence among 790 university students in Los Angeles, CA. Participants completed a questionnaire on potential risk factors before blood sampling. Samples were analyzed using the EUROIMMUN Anti-SARS-CoV-2 ELISA (IgG) for the qualitative detection of IgG class antibodies to SARS-CoV-2 in human serum or plasma.RESULTS:
The estimated prevalence of SARS-CoV-2 antibody was 4.0% (3.0%, 5.1%). Factors associated with having a positive test included history of anosmia and/or loss of taste (95% CI 1.4-9.6). A history of respiratory symptoms, with or without fever, was not associated with a positive antibody test.CONCLUSIONS:
Prevalence of SARS-CoV-2 antibodies in the undergraduate and graduate student university population was similar to community prevalence.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Students
/
Universities
/
Immunoglobulin G
/
Seroepidemiologic Studies
/
SARS-CoV-2
/
COVID-19
Type of study:
Observational study
/
Prognostic study
/
Qualitative research
/
Randomized controlled trials
Limits:
Adult
/
Female
/
Humans
/
Male
/
Young adult
Country/Region as subject:
North America
Language:
English
Journal:
J Adolesc Health
Journal subject:
Pediatrics
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS